Preclinical News and Research

RSS
EntreMed starts trial of ENMD-2076 in refractory multiple myeloma patients

EntreMed starts trial of ENMD-2076 in refractory multiple myeloma patients

AstraZeneca and Targacept announce results from trial of AZD3480 for cognitive dysfunction in schizophrenia

AstraZeneca and Targacept announce results from trial of AZD3480 for cognitive dysfunction in schizophrenia

Researchers discover why Gleevec-type drugs control, but do not eradicate leukemia

Researchers discover why Gleevec-type drugs control, but do not eradicate leukemia

Cytori reports benefit of adipose-derived regenerative cells in spinal disc model

Cytori reports benefit of adipose-derived regenerative cells in spinal disc model

Gene therapy used to fight AIDS

Gene therapy used to fight AIDS

MedImmune starts phase 2 trial of antibody targeting IL-5 receptor

MedImmune starts phase 2 trial of antibody targeting IL-5 receptor

Allos Therapeutics announces results from phase 2 trial of Pralatrexate in peripheral T-cell lymphoma

Allos Therapeutics announces results from phase 2 trial of Pralatrexate in peripheral T-cell lymphoma

Discovery of groundbreaking technique for body to accept gene therapy

Discovery of groundbreaking technique for body to accept gene therapy

SemBioSys begins phase I/II trial of insulin produced in plant seeds

SemBioSys begins phase I/II trial of insulin produced in plant seeds

Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer

Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer

Researchers develop human embryonic stem cell-based system for modeling ALS

Researchers develop human embryonic stem cell-based system for modeling ALS

New insight into adhesion and migration of dendritic cells could lead to novel cancer treatments

New insight into adhesion and migration of dendritic cells could lead to novel cancer treatments

Genaera starts trial of Trodusquemine in overweight and obese type 2 diabetes

Genaera starts trial of Trodusquemine in overweight and obese type 2 diabetes

Anadys Pharmaceuticals receives fast track for ANA598 treatment of chronic hepatitis C virus

Anadys Pharmaceuticals receives fast track for ANA598 treatment of chronic hepatitis C virus

Eli Lilly withdraws application for additional U.S. indication for Cymbalta for chronic pain

Eli Lilly withdraws application for additional U.S. indication for Cymbalta for chronic pain

MorphoSys and Galapagos enter alliance to co-develop novel therapeutic antibodies in bone and joint disease

MorphoSys and Galapagos enter alliance to co-develop novel therapeutic antibodies in bone and joint disease

Peregrine Pharmaceuticals awarded U.S. patent for anti-viral applications of phospholipid-targeting antibodies

Peregrine Pharmaceuticals awarded U.S. patent for anti-viral applications of phospholipid-targeting antibodies

Immune cells reveal fancy footwork

Immune cells reveal fancy footwork

Scientists develop peptide that converts Bcl-2 protein from a cancer cell's friend to a foe

Scientists develop peptide that converts Bcl-2 protein from a cancer cell's friend to a foe

Novel device enhances efficacy of standard chemotherapy

Novel device enhances efficacy of standard chemotherapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.